High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice

• Published in: Journal of Clinical Biochemistry and Nutrition 2011, Vol.49(2), pp.109-114
• Main Authors: Shiota, Asuka, Taketani, Yutaka, Maekawa, Yoichi, Yasutomo, Koji, Sata, Masataka, Sakai, Tohru, Mizuno, Risuke, Isshiki, Masashi, Yamamoto, Hironori, Takeda, Eiji
• Format: Article
• Language: English
• Subjects: apoptosis; atherosclerogenesis; chronic kidney disease; hyperphosphatemia; macrophage; Original
• ISSN: 0912-0009; 1880-5086
• DOI: 10.3164/jcbn.10-150

Although higher serum phosphate level is a risk factor for cardiovascular diseases in general population as well as chronic kidney disease patients, it has not been clarified whether higher phosphate can affect atherosclerotic plaque formation. In this study, we investigated the effect of prolonged-intake of different concentrations of phosphate on atherosclerosis formation using apolipoprotein E-deficient mice. Apolipoprotein E-deficient mice were fed with high fat diet including 0.6%, 1.2% or 1.8% phosphate. After 20-week treatment, atherosclerotic plaque formation in aorta in 1.8% phosphate diet group was unexpectedly less than that in the other groups. To elucidate mechanisms of suppression of plaque formation by high phosphate diet, we hypothesized that high phosphate diet may modify a profile of monocytes/macrophages suppressing plaque formation. We confirmed that elevated peripheral monocytes (CD11b+, F4/80+ cell numbers) in apolipoprotein E-deficient mice were decreased by feeding with 1.8% P diet. In addition, ex vivo study indicated that high dose of phosphate induced macrophage apoptosis. These observations suggest that excess phosphate intake decreased atherosclerosis formation, at least in part, by changing the profile of peripheral monocytes or inducing apoptosis of macrophages in apolipoprotein E-deficient mice.